The pharma companies moving fastest on AI are not deploying chatbots. They are automating the documentation workflows that consume thousands of hours per year. Here are the three areas where the early movers are seeing results.
1. Literature review and summary
A junior researcher reviewing literature for a single compound typically spends two to three days pulling relevant papers, extracting key findings, organizing them by study type, and formatting a summary for the team.
With Claude Code connected to PubMed or an internal literature database via MCP (Model Context Protocol), this workflow compresses to hours. The researcher defines the search criteria: compound name, mechanism of action, date range, study types of interest. Claude Code pulls the papers, extracts the relevant findings, and generates a structured summary organized by study design, sample size, primary endpoints, and key conclusions.
The researcher then reviews the summary. They verify that no relevant studies were missed. They check that the extracted findings accurately represent the original papers. They add context that requires domain expertise, the kind of interpretive judgment that AI cannot replicate.
The output is a literature review that took four hours instead of three days. The quality is equivalent or better because the AI does not skip papers due to fatigue, and the researcher's time is spent on evaluation rather than extraction.
2. Regulatory submission drafting
Regulatory submissions contain structured sections that follow predefined formats. Module 2 summaries, study synopses, tables of contents, and cross-reference indexes. These sections are time-intensive to draft because they require pulling data from multiple sources and formatting it according to regulatory templates.
Claude Code does not finalize these submissions. It drafts them. The AI pulls data from the clinical database, the study reports, and the existing submission templates. It generates the first draft of each section in the correct format.
The regulatory affairs team then reviews the drafts. They verify data accuracy. They correct any mischaracterizations. They add the regulatory context and strategic language that requires human expertise.
The reduction in drafting time is significant: what took a team two weeks of writing now takes two days of review. The regulatory affairs staff spend their time on high-value judgment work instead of data extraction and formatting.
3. Audit trail documentation
21 CFR Part 11 requires that electronic records in pharmaceutical environments maintain complete audit trails. Every change to a regulated document must be logged with who made the change, when, what was changed, and why.
In practice, this documentation frequently falls behind. Teams make changes in the moment and document them later, sometimes days or weeks after the fact. Retrospective audit trail entries are less accurate and less detailed than contemporaneous ones.
Claude Code can generate audit trail entries in real-time if the workflow is designed for it. When a researcher modifies a study protocol, the AI generates the change log entry at the moment of the change. When a regulatory document is updated, the audit trail entry is created simultaneously, not after the fact.
The key requirement: the CLAUDE.md must be configured with the specific format and content requirements for audit trail entries. What metadata must be captured. What level of detail is required. What regulatory standard the entries must satisfy.
What the early movers have in common
The pharma companies succeeding with these workflows share one characteristic: they built governance infrastructure before deploying AI tools.
Their CLAUDE.md files contain validation rules specific to pharmaceutical data. Human review checkpoints are designed into every workflow, not added as afterthoughts. Audit trails are built into the AI workflow itself, satisfying 21 CFR Part 11 requirements by design rather than by retrofit.
They did not start with tools. They started with governance. The tools followed.
Explore pharma enterprise training — our pharma enterprise track covers this workflow end to end.
Get posts like this in your inbox
No spam. New articles on AI strategy, governance, and building with AI for small business.